Search results for: Health Data and Statistics
Filter search results
ISPOR Task Force Report on Performance-Based Risk-Sharing Arrangements
28 August 2013
…of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes) and facilitates the translation of this research into useful information for health care decision makers. Its 7,000 members come…
Measurement and Management in the NHS
1 June 1989
…more rapid growth for example in home entertainment and electronics was seen as… The late John Vaizey posed a challenging question about the ‘explosion’ of health care costs in the…
Nancy Devlin
30 August 2023
…as a researcher and as an advisor to health care organisations, both in the public and private sectors, in the UK and internationally. Nancy is Professor of Health Economics and…
OHE at EuHEA 2016: Opportunity Costs, Value Based Pricing, Economies of Scope and Quality of Life
17 August 2016
…scope and scale in publicly funded biomedical and health research by Karla Hernandez-Villafuerte Publicly funded biomedical and health research is expected to achieve significant returns for taxpayers and for society…
Generating Preference-based Values for the EQ-5D-Y to Support Its Use in HTA
31 January 2019
OHE’s Koonal Shah and Oliver Rivero-Arias presented at a NICE Technical Forum on the topic of valuing health in children and adolescents. OHE’s Koonal Shah and Oliver Rivero-Arias recently presented…
Professor Lotte Steuten Appointed OHE Vice President and Head of Consulting
8 January 2019
…health and economic benefits of new approaches and interventions in disease prevention and treatment, and prioritizing data collection to efficiently build the evidence for promising new interventions. Announcing the appointment,…
OHE at ISPOR Latin America: Policy Options for Formulary Development in Middle-income Countries
20 October 2015
…catastrophic health expenditure); and that structured approaches (including simple forms of multi-criteria decision-analysis – MCDA) should be adopted to clearly define and combine the factors to consider and explicitly establish…
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?
1 June 2022
Gene therapies represent a new era of medicine, offering the potential for truly transformational health gains, and further benefits for society and health systems….
As UN General Assembly Highlights Tuberculosis Fight, Will BRICS Lead on the R&D Agenda?
26 September 2018
…pay for TB drugs and diagnostics out of government coffers. For BRICS, maintenance of the status quo—with subpar treatment options and growing drug resistance—implies an ever-expanding health and fiscal burden…